ArticleJournal of biopharmaceutical statistics2015

Seamless Phase I/II Adaptive Design for Oncology Trials of Molecularly Targeted Agents.

Nolan A Wages et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.